128 related articles for article (PubMed ID: 1564249)
1. Effects of subacute pyridostigmine administration on mammalian skeletal muscle function.
Adler M; Deshpande SS; Foster RE; Maxwell DM; Albuquerque EX
J Appl Toxicol; 1992 Feb; 12(1):25-33. PubMed ID: 1564249
[TBL] [Abstract][Full Text] [Related]
2. The effect of continuous pyridostigmine administration on functional (A12) acetylcholinesterase activity in guinea-pig muscles.
Lintern MC; Wetherell JR; Taylor C; Smith ME
Neurotoxicology; 2001 Dec; 22(6):787-93. PubMed ID: 11829412
[TBL] [Abstract][Full Text] [Related]
3. Neuromuscular toxicity of pyridostigmine bromide in the diaphragm, extensor digitorum longus, and soleus muscles of the rat.
Hudson CS; Foster RE; Kahng MW
Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S260-9. PubMed ID: 4092893
[TBL] [Abstract][Full Text] [Related]
4. Pyridostigmine-induced decrement in skeletal muscle contracture is not augmented by soman.
Anderson RJ; Chamberlain WL
Neurotoxicology; 1988; 9(1):89-96. PubMed ID: 3393305
[TBL] [Abstract][Full Text] [Related]
5. Effect of pyridostigmine pretreatment, HI-6 and Toxogonin treatment on rat tracheal smooth muscle response to cholinergic stimulation after organophosphorus inhalation exposure.
Walday P; Aas P; Haider T; Fonnum F
Arch Toxicol; 1993; 67(3):212-9. PubMed ID: 8494501
[TBL] [Abstract][Full Text] [Related]
6. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
Haigh JR; Adler M; Apland JP; Deshpande SS; Barham CB; Desmond P; Koplovitz I; Lenz DE; Gordon RK
Chem Biol Interact; 2010 Sep; 187(1-3):416-20. PubMed ID: 20144889
[TBL] [Abstract][Full Text] [Related]
7. Effects of subchronic pyridostigmine pretreatment on the toxicity of soman.
Shiloff JD; Clement JG
Can J Physiol Pharmacol; 1986 Jul; 64(7):1047-9. PubMed ID: 3768795
[TBL] [Abstract][Full Text] [Related]
8. Protection of human muscle acetylcholinesterase from soman by pyridostigmine bromide.
Maselli RA; Henderson JD; Ng J; Follette D; Graves G; Wilson BW
Muscle Nerve; 2011 Apr; 43(4):591-5. PubMed ID: 21404290
[TBL] [Abstract][Full Text] [Related]
9. Effect of repeated treatment with pyridostigmine on acetylcholinesterase in mouse muscles.
Lintern MC; Smith ME; Ferry CB
Hum Exp Toxicol; 1997 Mar; 16(3):158-65. PubMed ID: 9088969
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural effects of pyridostigmine on neuromuscular junctions in rat diaphragm.
Hudson CS; Foster RE; Kahng MW
Neurotoxicology; 1986; 7(1):167-85. PubMed ID: 3714119
[TBL] [Abstract][Full Text] [Related]
11. Continuous administration of pyridostigmine improves immobilization-induced neuromuscular weakness.
Frick CG; Helming M; Martyn JA; Blobner M; Fink H
Crit Care Med; 2010 Mar; 38(3):922-7. PubMed ID: 20009758
[TBL] [Abstract][Full Text] [Related]
12. Decreased tetanic contracture of rat skeletal muscle induced by pyridostigmine.
Anderson RJ; Chamberlain WL; Roesner M; Dacko C; Robertson DG
J Toxicol Environ Health; 1986; 18(2):221-30. PubMed ID: 3712486
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of guinea pig hemi-diaphragm acetylcholinesterase activity by pyridostigmine bromide and protection against soman toxicity.
Haigh JR; Johnston SR; Peters BM; Doctor BP; Gordon RK; Adler M; Gall KJ; Deshpande SS
Chem Biol Interact; 2005 Dec; 157-158():381-2. PubMed ID: 16429510
[No Abstract] [Full Text] [Related]
14. Effect of pyridostigmine on tetanic contracture of innervated and denervated rat skeletal muscle.
Anderson RJ
Neurotoxicology; 1987; 8(4):553-60. PubMed ID: 3441318
[TBL] [Abstract][Full Text] [Related]
15. The combined effects of pyridostigmine and chronic stress on brain cortical and blood acetylcholinesterase, corticosterone, prolactin and alternation performance in rats.
Kant GJ; Bauman RA; Feaster SR; Anderson SM; Saviolakis GA; Garcia GE
Pharmacol Biochem Behav; 2001; 70(2-3):209-18. PubMed ID: 11701190
[TBL] [Abstract][Full Text] [Related]
16. Effects of pyridostigmine on acetylcholinesterase in different muscles of the mouse.
Lintern MC; Smith ME; Ferry CB
Hum Exp Toxicol; 1997 Jan; 16(1):18-24. PubMed ID: 9023571
[TBL] [Abstract][Full Text] [Related]
17. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the toxicity, pathology, and treatment of cyclohexylmethylphosphonofluoridate (CMPF) poisoning in rhesus monkeys.
Koplovitz I; Gresham VC; Dochterman LW; Kaminskis A; Stewart JR
Arch Toxicol; 1992; 66(9):622-8. PubMed ID: 1482284
[TBL] [Abstract][Full Text] [Related]
19. Effect of pyridostigmine and syntostigmine pretreatment on the inhibition of acetylcholinesterases by o-pinacolyl-methylphosphonofluoridate. In vitro experiments with rat tissues.
Patocka J
Biomed Biochim Acta; 1989; 48(9):715-20. PubMed ID: 2619740
[TBL] [Abstract][Full Text] [Related]
20. The reversal by pyridostigmine of neuromuscular block produced by soman.
French MC; Wetherell JR; White PD
J Pharm Pharmacol; 1979 May; 31(5):290-4. PubMed ID: 37297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
